HMZ 2.0 Intervention for Pregnancy Weight Management
(HMZ Two Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to see if the enhanced HMZ 2.0 intervention with new control system/digital platform to regulate gestational weight gain (GWG) and impact maternal-infant outcomes while collecting implementation data works and can be given to other pregnant women in various settings. The question this study aims to answer are: 1. Does the new intervention manage GWG? 2. Does the new intervention have any influence on sleep and eating behaviors and infant outcomes. 3. Does the new platform and other data collected help inform how well the research and information can be used in health care settings? 144 pregnant women with overweight/obesity will be randomized to either the HMZ 2.0 intervention or attention control groups from \~8-36 weeks gestation. All participants will be asked to: 1. Weight themselves and wear an activity monitor each day over the study. 2. Complete online surveys at either a weekly or monthly level about their thoughts, attitudes, and behaviors on GWG, physical activity, eating behaviors, sleep, their anxiety, depression, and stress. 3. Attend weekly sessions with a registered dietician. The weekly sessions will differ based on intervention group. The HMZ 2.0 intervention group will receive education, create and follow goal-setting and action plans, self-monitor their behaviors, and receive feature evidence and fetal growth facts. Education, goals, and self-monitoring will focus on GWG, physical activity, eating behaviors, sleep, self-regulating behaviors and emotions, and preparing for labor/delivery and postpartum. The attention control group will receive weekly sessions on preparing for labor/delivery and benefits of behavioral pain management strategies (e.g., mindfulness-based relaxation, imagery, music, massage, deep-breathing) to help with pain after childbirth without medicine.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot be using weight loss medications to participate.
What data supports the effectiveness of the HMZ 2.0 Intervention for Pregnancy Weight Management treatment?
The research on psychological strategies and cognitive-behavioral methods for pain management suggests that increasing perceived control and using cognitive coping skills can be beneficial. These elements, which are part of the HMZ 2.0 Intervention, may help manage weight during pregnancy by promoting healthier behaviors and improving self-management.12345
Is the HMZ 2.0 Intervention for Pregnancy Weight Management safe for humans?
The studies reviewed focus on managing gestational weight gain through behavioral and educational interventions, which are generally considered safe for pregnant women. These interventions include providing information, motivational interviewing, and self-monitoring, all of which are non-invasive and have been associated with positive outcomes in managing weight gain during pregnancy.678910
How does the HMZ 2.0 Intervention for Pregnancy Weight Management differ from other treatments?
The HMZ 2.0 Intervention is unique because it combines behavioral strategies with adaptive dosages to manage gestational weight gain, focusing on personalized education and counseling sessions. It also uses mHealth tools for daily monitoring, which helps tailor the intervention to individual needs, unlike standard treatments that may not offer such personalized and technology-driven approaches.69111213
Research Team
Eligibility Criteria
This trial is for pregnant women aged 18-45, with a BMI of 25.0 to 45.0, living in specific areas of Pennsylvania. They must be at 8-15 weeks gestation and have their doctor's consent to participate. Women over a BMI of 40 will need extra checks from their healthcare provider.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention
Participants complete assessments and a 10-day free-living period to establish baseline data
Treatment
Participants engage in weekly sessions with a registered dietitian and daily self-monitoring using mHealth tools
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Attention Control Intervention (Behavioral Intervention)
- HMZ 2.0 Intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor
Arizona State University
Collaborator